Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 9, 2002, Pages 1090-1097

  McCracken, Eileen ^a   Fowler, Jill H ^a   Dewar, Deborah ^a   Morrison, Steve ^a   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Axons; Focal cerebral ischemia; Middle cerebral artery occlusion; Oligodendrocytes; Rat

Indexed keywords

2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID; 4 HYDROXYNONENAL; AMPA RECEPTOR ANTAGONIST; ISOQUINOLINE DERIVATIVE; OXIME DERIVATIVE; TAU PROTEIN; TAU1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GRAY MATTER; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PERIKARYON; PRIORITY JOURNAL; RAT; WHITE MATTER;

EID: 0036713689     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200209000-00006     Document Type: Article

References (48)

1. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury
2. 2+ influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes
3. EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons
4. AMPA receptor antagonists and local cerebral glucose utilization in the rat
5. Neuroprotective effect of the AMPA receptor antagonist LY 293558 in focal cerebral ischemia in the cat
6. 2+ overload and ROS generation in spinal motor neurons in vitro
7. Tau protein is altered by focal cerebral ischemia in the rat brain - An immunohistochemical and immunoblotting study
8. Drug development for stroke: Importance of protecting cerebral white matter
9. Intracerebral injection of AMPA causes axonal damage
10. Excitatory amino acid receptors in glia: Different subtypes for distinct function?
11. The pharmacology of α-amino-3-hydroxy-5-methy-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia
12. Ischemic penumbra: Evidence from functional imaging in man
13. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia
14. New method for the quantitative assessment of axonal damage in focal cerebral ischemia
15. Rapid alterations of tau in oligodendrocytes after focal ischemic injury in the rat: Involvement of free radicals
16. Threshold of focal cerebral ischemia in awake monkeys
17. White matter injury in spinal cord ischemia: Protection by AMPA/kainate glutamate receptor antagonism
18. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model
19. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction and death in the nervous system
20. The severity of ischemia and extent of axonal pathology in white matter after middle cerebral artery occlusion in the rat
21. Glycine antagonist (GV150526) in acute stroke: A multicenter, double-blind placebo-controlled phase II trial
22. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
23. +-dependent glutamate transport
24. Reversible middle cerebral artery occlusion without craniectomy in rats
25. Expression of heme-oxygenase-1 mediated by non-NMDA and metabotropic receptors in glial cells: Possible involvement of reactive oxygen species production and protein kinase C activation
26. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons
27. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
28. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes
29. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
30. SPD 502: A water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity
31. Quantitative assessment of early brain damage in a rat model of focal cerebral ischemia
32. Protective effect of the glutamate antagonist MK-801 in focal cerebral ischemia
33. Cerebral white matter is highly vulnerable to ischemia
34. Glial cells of the oligodendrocyte lineage express both kaniate-AMPA-preferring subtypes of glutamate receptors
35. Transformation of post-ischemic perineruonal glial cells. Part I: Electron microscopic studies
36. Selective glial vulnerability following transient global ischemia in rat brain
37. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures
38. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats
39. Multiple molecular penumbras after focal cerebral ischemia
40. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter
41. ZK200775: A phosphate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma
42. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: Attenuation of damage after transient ischemia
43. Disorders of the cerebral circulation
44. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX
45. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma
46. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia
47. α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage